Myocardial perfusion scintigraphy was performed in 30 intact anesthetized dogs following intracoronary injection of 99mTc-labeled human albumin microspheres (HAM). The normal dog myocardial image pattern was established. This technic detected myocardial infarcts resulting from small vessel occlusions and flush coronary branch occlusions when the coronary angiogram appeared normal. Myocardial infarcts as small as 112 cm were seen. Toxicologic studies in 47 dogs failed to demonstrate significant changes in blood pressure, heart rate, electrocardiogram, or serum CPK activity following intracoronary injections of HAM in doses up to 200 times that required for adequate myocardial scintigraphy. Gross and microscopic examination of hearts 1-6 weeks after HAM injection showed minor abnormalities also seen in matched controls receiving coronary arteriography alone. Preliminary results in 33 patients substantiate the safety of this technic. Human myocardial scintigrams reported here reveal anatomic detail not previously demonstrated by other external imaging methods.
injection in dogs? What is a safe yet effective dose? Can the technic detect myocardial infarction when the coronary angiogram is normal? What is its sensitivity for detecting small infarcts?
It is now recognized that there are patients who have normal coronary angiograms despite clinical or electrocardiographic evidence of myocardial ischemia or infarction.' Among the possible explanations for this apparent paradox are: (1) recanalization of a coronary thrombus following myocardial infarction;
(2) disease in vessiels too small to be seen on angiography; and (3) occlusion of a major coronary artery branch at its origin, flush with the parent vessel, so that absence of the branch is not appreciated on coronary angiography. A technic capable of detecting diminished myocardial vascularity at the arteriolar and capillary level should detect myocardial infarction or fibrosis even when the coronary arteriogram appears normal. If such a technic could accurately define the location and size of areas of diminished myocardial vascularity, it would help determine the functional significance of coronary lesions seen with coronary angiography. It would also be valuable for assessing the results of myocardial "revascularization" procedures.
Endo2 and Ashburn3 used intracoronary MAA labeled with 1'1I or 99mTc for myocardial imaging in man. The images were superior to earlier ones utilizing diffusable isotopes and impressed the authors with their great potential for diagnosis in coronary artery disease. The history of myocardial scintigraphic technics was well reviewed by Ashburn. 3 We chose human albumin microspheres for our study because this product, developed by the 3M Company and extensively tested by Rhodes, Burdine, and others,7' 14 seemed to have several advantages over MAA: (1) the particle size is uniform and consistent from batch to batch; (2) labeling with 99mTc is rapid and easy; (3) higher specific activities can be obtained, thereby reducing the number of particles needed for each image; and (4) an ultrasonic mixer can be used to assure complete dispersion of particles prior to injection.
Published experimental data on the effects of intracoronary albumin particles is limited. Available reports do not include detailed or controlled studies of histologic and serum myocardial enzyme changes4 5 and none includes studies on the effects of selective coronary HAM injection.
Materials and Methods

Animal Studies
We studied 47 mongrel dogs weighing from 16 kg to 26 kg. Intravenous pentobarbital anesthesia (25 mg/kg) was used in all dogs. A preformed coaxial polyethelyene catheter was introduced into a coronary artery through the left carotid artery under fluoroscopic control. The small nonobstructing inner catheter (4.1 F) was advanced approximately 2 cm into the left anterior descending or circumflex branch of the left coronary artery or the right coronary artery for injection of radiographic contrast medium or human albumin microspheres. Coronary angiograms were obtained used a rapid-sequence cutfilm technic. * Electrocardiograms and aortic or left ventricular pressures were recorded using an Electronics for Medicine or a four-channel directwriting Sanborn recorder and Statham P 23db pressure gauges. Myocardial scintigraphy was performed using a gamma scintillation camerat with a 16,000 parallel-hole, low-energy, highresolution collimator. Gating of the image to selected portions of the cardiac cycle was done in selected cases using an adjustable electronic gating device previously described.6 Gammacamera images were recorded simultaneously on Polaroid paper and 35-mm film. Human albumin microspheres: with a mean diameter of 22 micra, 95% falling between 16 and 30 micra, were used. They were supplied in dry form, sealed in sterile pyrogen-free labeling vials which contained all the reagents necessary for labeling. Each milliliter of prepared product contained 0.5 mg (75,000) microspheres. Details of the methods of preparation have been described elsewhere.7 8 The microspheres were labeled with 99mTc pertechnetate from a technetium generator. § For diagnostic studies we used a specific activity of 10-20 mCi *Elema-Schonander Corporation, Stockholm, Sweden.
tPho-Gamma III-HP, Nuclear Chicago Corporation, Des Plaines, Illinois.
43M-brand serum albumin microspheres (human). §Squibb Technetope, New Brunswick, New Jersey.
Circulation, Volume XLVI, November 1972 per mg of HAM, injecting 0.05 mg into each coronary artery. The microspheres were washed twice with saline after labeling, and the suspending solution normally contained less than 5% of the total activity. The physical half-life of 9gmTc is 6 hours, and the biologic half-life of albumin microspheres in tissue is less than 24 hours.7
Toxicologic studies were performed in 47 dogs. In 10 dogs the anterior descending or circumflex branch of the left coronary artery was injected with 0.5-2.0 mg HAM (10-40 times the diagnostic dose). Aortic pressure and the electrocardiogram were continuously recorded. In three other dogs massive doses of HAM (25-30 mg, or approximately 500 times the diagnostic dose) were injected into the left anterior descending coronary artery in small increments while we recorded the electrocardiogram and aortic or left ventricular pressure. Six dogs received left anterior descending and circumflex artery injections of 76% meglumine diatrizoate* plus 1.0-3.0 mg HAM, whereas six control dogs of similar size were injected with intracoronary contrast medium alone. Each of the 12 dogs was sacrificed 1 week after coronary artery injection for gross and histologic examination of heart tissues. Tissue samples were taken from the apex, septum, right ventricular free wall, anterolateral aspect of the left ventricle, and posterobasal aspect of the left ventricle of each heart, stored in formalin and later sectioned, mounted, and stained with hematoxylin and eosin, saffron, and periodic acid Schiff. Twelve additional dogs were studied in a similar manner after 6 weeks in order to detect any delayed histologic effects. In 10 dogs serum CPK activity was measured by the Sigma UV methodt on blood samples drawn before and at 4 hours, 24 hours, and 48 hours following coronary angiography plus anterior descending and circumflex injection of 0.5 mg HAM. Samples were obtained from 10 dogs which received intracoronary radiographic contrast medium alone and served as controls.
Myocardial scintigrams were obtained in 30 normal dogs. HAM was injected selectively into the right coronary artery, left anterior descending branch of the left coronary artery, circumflex branch of the left coronary artery, or combinations of these vessels in an attempt to define the normal myocardial scintigraphic pattern. Coronary artery ligation was performed in seven dogs, and all survived. In two, the left anterior descending coronary artery was ligated midway between its origin and the apex of the left ventricle. In three dogs the first large diagonal branch of the left anterior descending coronary artery was ligated flush with its origin from the left anterior descending artery, and infarction occurred in one. In two dogs a large branch of the circumflex artery was ligated at its origin and infarction occurred in one. Seven to thirteen days later coronary angiography and myocardial scintigraphy were performed on all seven dogs. The dogs were then sacrificed and their hearts examined to determine the extent of myocardial infarction. In six additional dogs the left anterior descending coronary artery was injected with carbonized microspherest in an attempt to produce myocardial infarction by small vessel occlusion. Carbonized spheres 250 micra in diameter were used in three dogs of which two died. The surviving dog exhibited an extensive anteroseptal infarct at autopsy. Carbonized spheres 20 micra in diameter were used in three dogs and all survived. All surviving dogs were subjected to coronary angiography and myocardial scintigraphy 7-14 days after injection of carbonized microspheres, followed by postmortem examination for evidence of myocardial infarction.
Human Studies
Patients were studied according to a protocol approved by the Committee on Human Research of the University of Cincinnati College of Medicine. § Thirty-three patients, 28 men and five women, who were already scheduled for diagnostic coronary angiography at the University of Cincinnati Medical Center agreed to participate after having been fully informed of the investigative nature of the study. Selective coronary catheterization was performed in each patient. After completion of the angiographic study of each coronary artery and before the catheter was removed, 0.05 mg HAM (7,500 particles) labeled with 0.5-1.0 mCi of 99mTc was injected into the catheter and slowly flushed into the coronary artery with 5 ml of saline. An ultrasonic mixer was used to disperse the microspheres immediately prior to injection. Coronary artery pressure and an electrocardiographic lead showing a large QRS deflection were continuously monitored in all patients and recordings made before and after coronary artery injection in most patients. If a left ventriculogram was obtained, left ventricular enddiastolic pressure was measured after HAM injection. Aliquots from each vial of HAM were tested for sterility, and pyrogen testing was done on 3; hour to 2 hours after HAM injection. One hundred thousand counts were collected for each scintigram, and a mininum of five views obtained in each patient: anterior, left lateral, right and left anterior oblique, and left posterior oblique. The time required for each scintigram varied from 2 to 10 min. If the scintigraphy time was short we obtained additional oblique views. For gated views we selected a 0.08-sec period just before the P wave for diastole and the apex of the T wave for systole, collecting 20,000 to 40,000 counts per scintigram.
Results
Dog Studies
Toxicity Figure Hours after coronary injection contrast injection alone. The mean CPK activity following intracoronary HAM is actually lower at each sampling period, but these data do not provide evidence for a significant difference when Student's t test is used (P values are shown). Arterial blood pressure and heart rate changed very little after HAM injection, the difference between group means being so small that it failed to provide evidence for a significant difference (P values are shown). Figure 2 demonstrates graphically the change in blood pressure and heart rate in one dog following incremental doses of intracoronary HAM into the anterior descending coronary artery. Only after injecting 10 mg HAM (200 times the diagnostic dose) did we record an increase in left ventricular enddiastolic pressure, followed by a rise in heart Mean serum CPK activity, arterial blood pressure, and heart rate following intracoronary HAM injection as compared to intracoronary injection of radiographic contrast medium alone. The brackets include 95% confidence limits for the mean. The number of observations in each group is indicated at the base of each bar. Students t-test was used to obtain P values (unpaired for CPK data, paired for pressure and heart rate data). rate, and eventually a precipitous drop in systolic blood pressure in this 20-kg dog.
Pathology Studies
Of sixty myocardial tissue sections obtained from the first group of 12 dogs (six received 10-40 times the diagnostic dose of HAM, and six controls received radiographic contrast only) one tissue section from each of two control dogs and a total of seven sections from three HAM-injected dogs showed abnormalities thought to be significant (myocytolysis). Except for one control dog with an organizing thrombus in a 200 micra-diameter artery, myocytolysis was restricted to minute patches, averaging approximately 1% of the crosssectional area of the positive slides from the control dogs and 0.75% of positive sections from HAM-injected dogs. Other findings such as focal chronic granuloma and epicardial calcification seen in two HAM-injected dogs were thought unlikely to have resulted from HAM injection 1 week before. One control dog exhibited a focus of granulomatous vasculitis. These data do not exclude the possibility that high doses of HAM (20-40 times the human diagnostic dose) produce minute areas of myocytolysis when myocardial tissue is examined within 1 week after Ciesculation, Volume XLVI, November 1972 injection, but we consider this unlikely for two reasons. First, myocytolysis was seen in two dogs receiving 1 and 2 mg HAM, respectively, whereas a dog receiving 3 mg HAM did not exhibit myocytolysis. Second, myocytolysis was also seen in two control dogs.
In the second group of experiments concluded at 6 weeks in which three to five times the diagnostic human dose was given, no myocytolysis was seen in sections from either control or HAM-injected dogs. The following abnormalities were noted only in dogs from the control group: focal granuloma, mild interstitial fibrosis, one minute focus of recent hemorrhage, and one focus of chronic active subendocardial interstitial inflammation without evidence of fiber damage. Figure 3 demonstrates, for purposes of orientation, the normal myocardial image patterns which result from injecting different coronary arteries in the dog. The dog's left coronary artery is so short as to be virtually nonexistent, and selective catheterization of the anterior descending and circumflex coronary arteries was necessary to insure a predictable distribution of microspheres in the left ventricle. Figure 4 displays myocardial scintigrams and coronary angiograms recorded before and 14 days after ligation of a large branch of the anterior descending coronary artery flush with its origin from the parent vessel at a point indicated by the arrow in panels A and B. Without the control angiogram it would be difficult to detect the absence of this large branch following ligation. Figure 5 demonstrates that the myocardial scintigram can detect myocardial infarction produced by arteriolar occlusion (20 micra-diameter carbonized microspheres) when the coronary angiogram appears normal.
Myocardial Scintigrams
Four additional dogs exhibited myocardial infarction at autopsy, and in each case the myocardial scintigram showed a defect corresponding to the anatomic site of infarction. Two additional dogs did not develop myocar- dial inifarction following coronary branch ligation, and in each case the myocardial image after ligation was uncehanged from that obtainied before ligationi.
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Figure 5
Detection of a myocardlial inifarct by mycoardial scintigraphy wvhen the coronary angiogram wvas normal. The inifarct (C) was produced by small vessel occlusion following injection of carbonized microspheres into the left anterior descending coroniary artery (LAD CA). Upper panels: (A andi B) Normal LAD CA and circunmflex (CIR CA) coronary arteries. The auitopsy specnnen, (C) revealed a high anterolateral myocardial infarct (arrowts). Middle panels: Normal control scintigrasms before small vessel occlusion. Lower panels: Scintigraphic defects (arrow;s) corresponded to thfe anatomic site of infarction.
Electronic galtinig of the sciuitigram by meanis of electrocardiogram signail did niot improve the resolutioln of the system anid greatly proloniged the time required to obtaini each image. It was the-reforeal)andone(l.
Clinical Studies
Toxieitl Table 1 Average systolic BP before HAM injection = 98 20 SD (mm Hg). Average systolic BP after HAM injection = 102 22 SD. Average diastolic BP before HAM injection = 66 12 SD. Average diastolic BP after HAM injection = 69 -12 SD.
(asterisks). However, arterial pressures and the ECG were continuously monitored by a physician during each procedure, and no change in these variables was observed at the time of HAM injection. Although the differences between means are small, analysis of the recorded change in blood pressure following HAM injection (Student t test for paired differences) provided evidence for a significant increase in both systolic and diastolic blood pressure. This was probably due to the Circulation, Volume XLVI, November 1972 commonly observed upward drift in blood pressure following the drop caused by intracoronary contrast injection. HAM was injected during this recovery period. Intracoronary HAM injection did not produce electrocardiographic changes in any patient. Left ventricular end-diastolic pressure was measured following intracoronary HAM and radiographic contrast injection in 19 patients. It was elevated (greater than 11 mm Hg) in two patients, each of whom had an extensive anterior wall inifarct, cardiomegaly, anid myocardial aneurysm. LVEDP was measured both before and after radiographic contrast and HAM injection in one patient, and it did not chanige. Figure 6 shows the angiographic and scintigraphic abnormalities found in patient E.M., a 45-year-old man with Fredrickson type 11 hyperlipoproteinemia and clinical and electrocardiographic evidence of an acute anteroseptal myocardial infarctioni 4 months prior to this study. Figure 7 shows the angiographic and myocardial image findings in F. W., a 51-year-old man who developed cliniical anid electrocardiographic evidence of acuite inferior myocardial infarction 7 months prior to this study. Included for comparison are the sciintigrams from R. L., a 41-year-old man without clinical evidence of myocardial itnfarction whose myocardial image was thought to be niormal. Inferior itnfarct in patient F.W. The coronary angiogram (A) demonstrated complete occlusion of the rig/it coronaryl artery (arrow). The left ventricuilogram (B, diastole; C, systole) s/towed moderate hypokinesis of the inferior wall. The arrowvs in C indicate the excursion of ventricular wvalls du.ring systole (broken line represents the diastolic dimensions). Middle 1)anels showl dlinminished radioactivity in the inferoposterior sea/I of the left ventricle, seltum, and inferior wvall of the right ventricle (arrows). Lower panels: Corresponding views of a tnornal pattern from another patient, RIL., who had no clinical evidence of snyocardlial inifarction and whzose mylocardial scintigram * was considered normal. Hyperconcentration of radioactivity in the distribution of the proximal right coronary artery (note scinitillations in area of the atriufm in D) inldicates a .smaller vascular bed on the right, in this case presumed to be due to obstruction of the right coronary artery.
Myocardial Scintigrarnls
Discussion
It is reasonable to assume that radioactive microsphere distribution accurately reflects blood flow distribution, based on experience with carboniized microspheres'12 anid MAA particles.'1 The theoretic considerations and validationi of the method are summarized by Wagner in a recenit review.14 Domenech and his associates12 demonstrated that certaini aniatomic fcatures of the coroniary circulation caused nionihomogenieous myocardial distribu-tionI of microspheres 50 micra in diameter or lar.ger, whler-eas smaller microspheres such as those uised in this study were more uniformly distributed.
The largest experience witlh hlnuman albumini iicrospheres has beeni reported by Rhodes an his associates.'3 They have performiied Cinrcuaiion, Volume XLVI. November 1972 973 I lunig scanis usiiig HAM since 1968 and report only five adverse reactions in more than 1,500 initravenous injections. These reactions were brief and self-limited. Only two possible adverse reactions, both self-limited, occurred in 5,700 patients who received 3M-brand HAM for lung scanning, according to investigator reports submitted to the 3M Company during clinical trials (Hoogland DR: Personal communication). Rhodes7 demonstrated that the LD-50 for intravenous HAM injection in mice was greater than 200 mg per kg or 5,000 times the normalized human dose and that HAM was less toxic than MAA or ferric hydroxide particles. Burdine14 performed histologic studies in dogs following intravenous, carotid artery, renal artery, and celiac artery injections of HAM and observed no ischemic, hemorrhagic, or necrotic changes. Fortuin and co-workers'5 recently measured coronary blood flow, peak reactive hyperemic coronary blood flow, cardiac output, mean aortic pressure, and heart rate following injection of 15-micra carbonized microspheres into the dog's left atrium. Assuming that 5% of the cardiac output went to the coronary circulation, they found no significant change in these variables following intracoronary doses as largeas 200,000 particles. Peak reactive hyperemic coronary blood flow was unaltered with intracoronary doses as large as 600,000 particles.
The normal myocardium is an extremely vascular tissue containing about 4,000 capillaries/mm2 cross-sectional area, one for each muscle fiber.'6 The ability of the heart to tolerate embolization with small particles when the dose is carefully controlled probably reflects the small proportion of the total capillary and arteriolar bed occluded. If we assume homogeneous distribution in a 300-g heart, the final microsphere density would be only 50 particles/cc when a 0.1-mg HAM dose is used. It has been feared that albumin microspheres may be more hazardous than MAA because the spherical nature of the particles produces a ' . . . propensity for total plugging of the vessel in which they lodge and probably resultant slower clearance. "4 This fear is not borne out by the results of our toxicity studies.
Ashburn3 modified his method of MAA production and labeling, enabling him to reduce the number of particles required for a heart scan from approximately 400,000 to 200,000. With HAM, very high specific labeling activities can be obtained, allowing us to further reduce the number of particles required for heart imaging to approximately 15,000.
The use of radioactive-labeled HAM for myocardial scintigraphy is investigational. We have observed no adverse reactions during our limited experience with patients, but there may be unforeseen hazards, evident only after more patients are studied and longer followup is obtained. Further, the diagnostic usefulness of the procedure for patients has not yet been established. Interpretation of myocardial images is a deductive process at present, and it remains to be shown that myocardial scintigraphy provides information not obtainable using existing technics such as contrast ventriculography, cardiac fluoroscopy, and electrocardiography. The future usefulness of the technic can be judged only after correlation with clinical, surgical, and autopsy findings. However, our animal data indicate that recent infarcts as small as 1% cm in diameter may be detected, and myocardial infarcts resulting from small vessel occlusion and "flush occlusions" may be detected by myocardial scintigraphy even when the coronary arteriogram appears normal.
To be interpretable, myocardial scintigrams must demonstrate myocardial anatomy and be able to distinguish small defects in the coronary circulation. Our method employs clinical scintigraphy equipment designed for high-resolution scintigraphy when using 99mTc, an isotope having a nearly ideal energy peak for this purpose. This may explain why the scintigrams reported here show anatomic detail not demonstrated in previous reports dealing with myocardial perfusion scintigraphy.
